Market Access, Pricing, and Reimbursement News in the First Quarter of 2009

Title	Published	Price
Snapshots US Pharmaceuticals 2009 By: Snapdata International Group Snapdata's Snapshots US Pharmaceuticals 2009 provides 2008 year-end market size data, with 2009 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the US pharmaceutical market and \| more... Search inside this report	11/12/2009	$600.00
Pharmaceuticals Industry Report By: Plimsoll Publishing Ltd. The Global Pharmaceuticals Industry Report Plimsoll Publishing Ltd. Do you know.... The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels of debt? This report is an in-depth financial \| more...	11/1/2009	$1,500.00
Antipsychotics Market Forecast By: Datamonitor Introduction In 2008, seven major market sales of antipsychotics reached $18.2 billion. Datamonitor forecasts the market value to peak in 2011 when it will then succumb to generic erosion, particularly in the US where incursion is \| more...	10/28/2009	$15,200.00
Commercial Insight: Antidiabetics in Australia - Reimbursement status shapes novel classes By: Datamonitor Introduction Datamonitor expects the Australian antidiabetics market to reach $416m by 2018. The growth will be driven by the launch of new drug classes, notably the incretin mimetics, and large growth in patient numbers. Although strongest \| more...	10/20/2009	$5,700.00
Prescription Drug Wholesaling in the US - Industry Risk Rating Report By: IBISWorld Industry Risk Ratings Synopsis This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Prescription Drug Wholesaling in the US industry. Industry Risk is assumed to be 'the difficulty, or otherwise, of \| more... Search inside this report	10/17/2009	$825.00
Health & Welfare Funds in the US - Industry Risk Rating Report By: IBISWorld Industry Risk Ratings Synopsis This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Health & Welfare Funds in the US industry. Industry Risk is assumed to be 'the difficulty, or otherwise, \| more... Search inside this report	10/17/2009	$825.00
Antidepressants Market Forecast By: Datamonitor Introduction With current blockbuster brands facing generic competition, Datamonitor forecasts the antidepressant market to decline at a compound annual growth rate of -2.0% (20082018). However, an antidepressant with a novel mechanism of action has huge commercial \| more...	10/13/2009	$15,200.00
Snapshots France Pharmaceuticals 2009 By: Snapdata International Group Snapdata's Snapshots France Pharmaceuticals 2009 provides 2007 year-end market size data, with 2008 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the French pharmaceutical market and \| more... Search inside this report	10/12/2009	$600.00
The US Government's Financial Support to Push Comparative Effectiveness Research By: GlobalData Summary GlobalData's new report - "The US Government’s Financial Support to Push Comparative Effectiveness Research", explores the US medical equipment industry and the intricacies of the economic stimulus bill. The US Congress in the early part \| more...	10/12/2009	$500.00
Snapshots Australia Pharmaceuticals 2009 By: Snapdata International Group Snapdata's Snapshots Australia Pharmaceuticals 2009 provides 2007 year-end market size data, with 2008 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the Australian pharmaceutical market and \| more... Search inside this report	10/12/2009	$600.00

Phone: 800.298.5699 (US) or +1.240.747.3093 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: customerservice@marketresearch.com
Copyright © 1999-2009, All Rights Reserved, MarketResearch.com
11/22/2009 - 3